227 related articles for article (PubMed ID: 23137165)
1. Tanshinone IIA inhibits metastasis after palliative resection of hepatocellular carcinoma and prolongs survival in part via vascular normalization.
Wang WQ; Liu L; Sun HC; Fu YL; Xu HX; Chai ZT; Zhang QB; Kong LQ; Zhu XD; Lu L; Ren ZG; Tang ZY
J Hematol Oncol; 2012 Nov; 5():69. PubMed ID: 23137165
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of cytochrome P450 2J2 by tanshinone IIA induces apoptotic cell death in hepatocellular carcinoma HepG2 cells.
Jeon YJ; Kim JS; Hwang GH; Wu Z; Han HJ; Park SH; Chang W; Kim LK; Lee YM; Liu KH; Lee MY
Eur J Pharmacol; 2015 Oct; 764():480-488. PubMed ID: 26209360
[TBL] [Abstract][Full Text] [Related]
3. Plantamajoside inhibits the proliferation and epithelial-to-mesenchymal transition in hepatocellular carcinoma cells via modulating hypoxia-inducible factor-1α-dependent gene expression.
Yin W; Xu J; Li C; Dai X; Wu T; Wen J
Cell Biol Int; 2020 Aug; 44(8):1616-1627. PubMed ID: 32239594
[TBL] [Abstract][Full Text] [Related]
4. Tanshinone IIA normalized hepatocellular carcinoma vessels and enhanced PD-1 inhibitor efficacy by inhibiting ELTD1.
Mao D; Wang H; Guo H; Che X; Chen M; Li X; Liu Y; Huo J; Chen Y
Phytomedicine; 2024 Jan; 123():155191. PubMed ID: 38000104
[TBL] [Abstract][Full Text] [Related]
5. Metformin sensitizes sorafenib to inhibit postoperative recurrence and metastasis of hepatocellular carcinoma in orthotopic mouse models.
You A; Cao M; Guo Z; Zuo B; Gao J; Zhou H; Li H; Cui Y; Fang F; Zhang W; Song T; Li Q; Zhu X; Yin H; Sun H; Zhang T
J Hematol Oncol; 2016 Mar; 9():20. PubMed ID: 26957312
[TBL] [Abstract][Full Text] [Related]
6. A novel tripeptide, tyroserleutide, inhibits irradiation-induced invasiveness and metastasis of hepatocellular carcinoma in nude mice.
Jia JB; Wang WQ; Sun HC; Liu L; Zhu XD; Kong LQ; Chai ZT; Zhang W; Zhang JB; Xu HX; Zeng ZC; Wu WZ; Wang L; Tang ZY
Invest New Drugs; 2011 Oct; 29(5):861-72. PubMed ID: 20414698
[TBL] [Abstract][Full Text] [Related]
7. Bufalin suppresses hepatocellular carcinoma invasion and metastasis by targeting HIF-1α via the PI3K/AKT/mTOR pathway.
Wang H; Zhang C; Xu L; Zang K; Ning Z; Jiang F; Chi H; Zhu X; Meng Z
Oncotarget; 2016 Apr; 7(15):20193-208. PubMed ID: 26958938
[TBL] [Abstract][Full Text] [Related]
8. Tanshinone II-A inhibits invasion and metastasis of human hepatocellular carcinoma cells in vitro and in vivo.
Yuxian X; Feng T; Ren L; Zhengcai L
Tumori; 2009; 95(6):789-95. PubMed ID: 20210245
[TBL] [Abstract][Full Text] [Related]
9. Residual hepatocellular carcinoma after oxaliplatin treatment has increased metastatic potential in a nude mouse model and is attenuated by Songyou Yin.
Xiong W; Ren ZG; Qiu SJ; Sun HC; Wang L; Liu BB; Li QS; Zhang W; Zhu XD; Liu L; Wang WQ; Tang ZY
BMC Cancer; 2010 May; 10():219. PubMed ID: 20487542
[TBL] [Abstract][Full Text] [Related]
10. Herbal extract "Songyou Yin" inhibits tumor growth and prolongs survival in nude mice bearing human hepatocellular carcinoma xenograft with high metastatic potential.
Huang XY; Wang L; Huang ZL; Zheng Q; Li QS; Tang ZY
J Cancer Res Clin Oncol; 2009 Sep; 135(9):1245-55. PubMed ID: 19277711
[TBL] [Abstract][Full Text] [Related]
11. Brucine, an alkaloid from seeds of Strychnos nux-vomica Linn., represses hepatocellular carcinoma cell migration and metastasis: the role of hypoxia inducible factor 1 pathway.
Shu G; Mi X; Cai J; Zhang X; Yin W; Yang X; Li Y; Chen L; Deng X
Toxicol Lett; 2013 Oct; 222(2):91-101. PubMed ID: 23933019
[TBL] [Abstract][Full Text] [Related]
12. Tanshinone IIA induced cell death via miR30b-p53-PTPN11/SHP2 signaling pathway in human hepatocellular carcinoma cells.
Ren X; Wang C; Xie B; Hu L; Chai H; Ding L; Tang L; Xia Y; Dou X
Eur J Pharmacol; 2017 Feb; 796():233-241. PubMed ID: 27894814
[TBL] [Abstract][Full Text] [Related]
13. Combined Treatment of Tanshinone I and Epirubicin Revealed Enhanced Inhibition of Hepatocellular Carcinoma by Targeting PI3K/AKT/HIF-1α.
Zhao J; Lin E; Cai C; Zhang M; Li D; Cai S; Zeng G; Yin Z; Wang B; Li P; Hong X; Chen J; Zou B; Li J
Drug Des Devel Ther; 2022; 16():3197-3213. PubMed ID: 36158238
[TBL] [Abstract][Full Text] [Related]
14. Chinese herbal formula QHF inhibits hepatocellular carcinoma metastasis via HGF/c-Met signaling pathway.
Yuan S; Gong Y; Chen R; Du J; Zhang H; Chen T
Biomed Pharmacother; 2020 Dec; 132():110867. PubMed ID: 33075668
[TBL] [Abstract][Full Text] [Related]
15. Tanshinone IIA reduces secretion of pro‑angiogenic factors and inhibits angiogenesis in human colorectal cancer.
Zhou L; Sui H; Wang T; Jia R; Zhang Z; Fu J; Feng Y; Liu N; Ji Q; Wang Y; Zhang B; Li Q; Li Y
Oncol Rep; 2020 Apr; 43(4):1159-1168. PubMed ID: 32323837
[TBL] [Abstract][Full Text] [Related]
16. Herbal compound "Songyou Yin" reinforced the ability of interferon-alfa to inhibit the enhanced metastatic potential induced by palliative resection of hepatocellular carcinoma in nude mice.
Huang XY; Huang ZL; Wang L; Xu YH; Huang XY; Ai KX; Zheng Q; Tang ZY
BMC Cancer; 2010 Oct; 10():580. PubMed ID: 20969807
[TBL] [Abstract][Full Text] [Related]
17. Incomplete radiofrequency ablation enhances invasiveness and metastasis of residual cancer of hepatocellular carcinoma cell HCCLM3 via activating β-catenin signaling.
Zhang N; Wang L; Chai ZT; Zhu ZM; Zhu XD; Ma DN; Zhang QB; Zhao YM; Wang M; Ao JY; Ren ZG; Gao DM; Sun HC; Tang ZY
PLoS One; 2014; 9(12):e115949. PubMed ID: 25542041
[TBL] [Abstract][Full Text] [Related]
18. [Effects of the Chinese herbal extract Songyou Yin on the residual hepatocellular carcinoma after chemotherapy in nude mice].
Xiong W; Tang ZY; Ren ZG; Huang XY; Jia QA; Xie XY; Shen HJ
Zhonghua Zhong Liu Za Zhi; 2013 Nov; 35(11):804-7. PubMed ID: 24447475
[TBL] [Abstract][Full Text] [Related]
19. Galactose-Modified PH-Sensitive Niosomes for Controlled Release and Hepatocellular Carcinoma Target Delivery of Tanshinone IIA.
Hu X; Zhang J; Deng L; Hu H; Hu J; Zheng G
AAPS PharmSciTech; 2021 Mar; 22(3):96. PubMed ID: 33694067
[TBL] [Abstract][Full Text] [Related]
20. Targeting the Ang2/Tie2 Axis with Tanshinone IIA Elicits Vascular Normalization in Ischemic Injury and Colon Cancer.
Zou W; Qian C; Zhang S; Wan X; Wei Z; Li X; Wu Y; Chen W; Wang A; Zhao Y; Lu Y
Oxid Med Cell Longev; 2021; 2021():7037786. PubMed ID: 34804370
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
